(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one

C35H61NO3Si — CID 11050077

IUPAC(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one
SMILESCCCCCCCCCCCCC/C=C/[C@@H]1OC(=O)N(Cc2ccccc2)[C@H]1CO[Si](C(C)C)(C(C)C)C(C)C
InChIInChI=1S/C35H61NO3Si/c1-8-9-10-11-12-13-14-15-16-17-18-19-23-26-34-33(28-38-40(29(2)3,30(4)5)31(6)7)36(35(37)39-34)27-32-24-21-20-22-25-32/h20-26,29-31,33-34H,8-19,27-28H2,1-7H3/b26-23+/t33-,34-/m0/s1
InChIKeyOHJCZYJDUPHIHF-HRZJYXCNSA-N
MW571.96 g/mol
LogP10.83
Rot. Bonds21

About (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one

(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one (PubChem CID 11050077) has the molecular formula C35H61NO3Si and a molecular weight of 571.96 g/mol. Its IUPAC name is (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one
PubChem CID11050077
Molecular FormulaC35H61NO3Si
Molecular Weight571.96 g/mol
Exact Mass571.44
IUPAC Name(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one
SMILESCCCCCCCCCCCCC/C=C/[C@@H]1OC(=O)N(Cc2ccccc2)[C@H]1CO[Si](C(C)C)(C(C)C)C(C)C
InChIInChI=1S/C35H61NO3Si/c1-8-9-10-11-12-13-14-15-16-17-18-19-23-26-34-33(28-38-40(29(2)3,30(4)5)31(6)7)36(35(37)39-34)27-32-24-21-20-22-25-32/h20-26,29-31,33-34H,8-19,27-28H2,1-7H3/b26-23+/t33-,34-/m0/s1
InChIKeyOHJCZYJDUPHIHF-HRZJYXCNSA-N
XLogP10.83
TPSA38.77 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds21
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500571.96
LogP ≤ 510.83
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one?
The IUPAC name of (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one (CID 11050077) is (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one.
What is the SMILES notation for (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one?
The canonical SMILES for (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one is CCCCCCCCCCCCC/C=C/[C@@H]1OC(=O)N(Cc2ccccc2)[C@H]1CO[Si](C(C)C)(C(C)C)C(C)C.
What is the InChIKey of (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one?
The InChIKey is OHJCZYJDUPHIHF-HRZJYXCNSA-N. The full InChI is InChI=1S/C35H61NO3Si/c1-8-9-10-11-12-13-14-15-16-17-18-19-23-26-34-33(28-38-40(29(2)3,30(4)5)31(6)7)36(35(37)39-34)27-32-24-21-20-22-25-32/h20-26,29-31,33-34H,8-19,27-28H2,1-7H3/b26-23+/t33-,34-/m0/s1.
What are the key properties of (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one?
(4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one has a molecular weight of 571.96 g/mol, XLogP of 10.83, 21 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,5S)-3-benzyl-5-[(E)-pentadec-1-enyl]-4-[tri(propan-2-yl)silyloxymethyl]-1,3-oxazolidin-2-one is sourced from PubChem (CID 11050077), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).